Related by context. Frequent words. (Click for all words.) 76 AVI BioPharma Inc. 70 Inc. Nasdaq IMGN 69 Inc. NASDAQ MRNA 65 Nasdaq VRTX 65 Idera Pharmaceuticals 65 Nasdaq ENZN 64 Inc. Nasdaq NEXM 64 NASDAQ LGND 63 Inc. Nasdaq SEPR 63 Nasdaq ASTM 63 Nastech Pharmaceutical Company 63 Inovio Biomedical Corporation 63 Metabasis Therapeutics Inc. 63 Synergy Pharmaceuticals 63 OncoGenex Pharmaceuticals Inc. 63 AEMD 62 Nasdaq BIIB 62 Initiates Phase II 62 NASDAQ ARIA 62 gets USFDA nod 62 Inc. NASDAQ TRGT 62 OTCBB AEMD 62 NASDAQ CRXL 61 Callisto Pharmaceuticals Inc. 61 Nasdaq REGN 61 NASDAQ IMCL 61 Rosetta Genomics Ltd. 61 Inc. NASDAQ CLDA 61 immunotherapeutics 61 Nasdaq ISIS 61 Inc Therapeutic Competitors 61 NASDAQ CYPB 60 NYSE Amex INO 60 Nasdaq XOMA 60 Healthnostics Inc. 60 Simulations Plus Inc. 60 LYON France BUSINESS WIRE 59 Alexza Pharmaceuticals Inc. 59 MorphoSys AG FSE MOR 59 Ligand Pharmaceuticals Incorporated 59 novel orally administered 59 Nasdaq BDSI 59 Inc. NASDAQ ZGEN 59 ImmunoCellular Therapeutics 59 AVEO Pharmaceuticals 59 Preclinical Data 59 Drug Candidate 59 Crucell NV Euronext 59 Inc. NASDAQ SNTS 59 submitted Biologics License 59 Roche SIX RO 59 targeting CD# 59 OTCQX RHHBY 59 Sunesis Pharmaceuticals Inc. 59 Bayhill Therapeutics 59 Celsion Corporation 59 EntreMed Inc. 58 Santaris 58 TLR9 agonist 58 HAYWARD Calif. BUSINESS WIRE 58 Halozyme Therapeutics Inc. 58 ARIAD Pharmaceuticals Inc. 58 PRNewswire FirstCall BioMarin Pharmaceutical 58 Factor VIIa 58 Fluidigm Corporation 58 proteasome inhibitor 58 NASDAQ OSIR 57 AVI BioPharma 57 Trubion Pharmaceuticals Inc. 57 DURHAM NC BUSINESS WIRE 57 SCOLR Pharma Inc. 57 Cephalon NASDAQ CEPH 57 Inc. OTCBB OOIL 57 Initiate Phase 57 EMERYVILLE Calif. BUSINESS WIRE 57 Inc. NASDAQ AFFX 57 Response Genetics Inc. 57 addressing idiopathic pulmonary 57 Adeona Pharmaceuticals Inc. 56 Trubion Pharmaceuticals 56 TSX TLN 56 R sorafenib tablets 56 optical biosensors 56 Inc. Nasdaq CLRT 56 NASDAQ DYAX 56 humanized anti 56 FDA Accepts 56 Covalon Technologies Ltd. 56 fibrosis IPF 56 liposomal formulation 56 Recombinant Human 56 PRNewswire FirstCall Cell Therapeutics 56 orally bioavailable 56 Commences Phase 56 Targeted Genetics Corporation 56 Calistoga Pharmaceuticals 56 Pharmion Corporation 56 PHARM 56 Inovio Pharmaceuticals 56 Vicor Technologies Inc. 55 Inc. Nasdaq AFFX